So in terms of curing cancer... where does this get us? (i'm not being sarcastic. it sounds very promising but I don't know enough on the topic to judge how significant it is)
First of all, don't ever trust a popular science writeup from the school of the corresponding author. It is almost certainly meaningless hype. Secondly, PNAS is a good journal, but not a great one. He was almost certainly rejected from the top tier. (Nature, Science) As someone who works in this field, finding genes that are similar in some way to two disease related genes is not at all novel. This is the goal of lit…
A key question here is how many other pathways did they try this on before they got it to "work" on 10/14 (though really 10/60) B-cell-associated genes? I'm not asserting that they mined for the most favorable pathway, but I will say that this one example comes across as more of an anecdote than a proof of concept.
People are going to be using this tool perhaps hundreds of thousands of times. Don't show me one example where 10/14 genes "validated." Show me 20 examples where X out of N genes validate - if that's sufficiently high, I'll be much more interested.
Even the developmental focus of this new tool is fairly common practice by those in the field. Look at the Seidman lab or the Walsh lab at Boston Children's to see examples of other people thinking deeply about how developmental biology ties back into adult pathology.